Skip to main content
All lobbying filings

ARKEMA INC. AND ITS AFFILIATES (FKA ARKEMA INC.)

Lobbying for ARKEMA INC. AND ITS AFFILIATES (FKA ARKEMA INC.)

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Expenses
$168,000
What this organization spent lobbying with its own staff. Reported using IRS section 162(e) definitions (method C): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
Pennsylvania

Official filing document

 Government bodies contacted 8

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 14

Superfund fees issues; H.R. 640 / S. 615 H.R. 1 - Budget reconciliation One Big Beautiful Bill Act implementation - business and international tax issues and related issues Budget reconciliation issues

H.R. 1 - Budget Reconciliation - One Big Beautiful Bill Act and related issues (implementation) Composite materials; advanced materials; R&D Budget reconciliation issues H.R. 9495/S. 4784 FY27 Defense Appropriations bill

Issues related to rail transportation, rail safety, rail labor issues, rail tank cars, rail-shipper matters, rail competition and/or competitive switching, and shipping issues. Monitor rail safety legislation. Monitor rail service legislation.

Issues related to antidumping/trade remedies matters, tariffs (including Section 301 and 232 tariffs and import issues), duty suspensions, exports/imports, and HFC issues Issues related to tariffs under the International Emergency Economic Powers Act (IEEPA) and/or other current tariffs and tariff policies/announcements. Issues related to USMCA

Biobased materials (monitor)

Clean Air Act regulations; Montreal Protocol (including the Kigali Amendment), the Paris Agreement, climate and/or fluorochemicals and hydrofluorocarbons issues and Significant New Alternatives Policy program American Innovation and Manufacturing Leadership Act implementation and regulations (AIM Leadership Act H.R. 5544/S. 2754 - 116th Congress)

Toxic Substances Control Act (TSCA) implementation, including new and existing chemicals regulations and new chemicals approvals and other chemical regulations and/or chemical management issues, including remediation, superfund, consumer and/or other issues. Issues related to fluorochemicals, fluoropolymers, hydrofluorocarbons, and/or Montreal Protocol (including the Kigali Amendment) and/or the Paris Agreement Significant New Alternatives Policy program regulations. Issues and legislation related to per- and polyfluoroalkyl substances/materials Chemical manufacturing issues and chemical products and/or materials. Supply chains, including critical supply chain materials Monitor potential FDA regulations and/or legislation regarding additives and/or packaging

Issues related to advanced materials, composites, thermoplastics, and/or materials and specifications; manufacturing; R&D; remediation H.R. 9495/S. 4784 FY27 Defense Appropriations bill

Issues related to energy, energy infrastructure, alternative/renewable energy, alternative/renewable fuel, hydrogen, vehicle technology, building technology/construction, building codes, energy efficiency, energy storage, solar, biobased materials, natural gas and natural gas storage, innovative manufacturing, refrigerants, industrial energy, carbon sequestration and transportation, pipelines, composite materials for utility and energy infrastructure, 3D printing, and energy permitting issues.

Issues related to Clean Air Act regulations, climate change, sustainability issues, recycling, stratospheric ozone protection, greenhouse gas reporting, fluorochemicals, hyrdofluorocarbons and/or refrigerants; and/or the Montreal Protocol (including the Kigali Amendment) and United Nations supporting language and the Paris Agreement; UN plastics treaty issues. EPA chemical regulations, including Significant New Alternatives Policy program regulations Climate change/sustainability issues Chemical manufacturing issues

Chemical Facility Antiterrorism (CFATS) reauthorization (monitor)

Critical Supply Chain Issues Chemical and materials manufacturing/trade issues and data center R&D and manufacturing issues

Issues related to trade agreements Issues related to antidumping matters/trade remedies, tariffs (including Section 301 and 232 tariffs and import issues), duty suspensions, exports/imports, and HFC issues Issues related to tariffs under International Emergency Economic Powers Act (IEEPA) and/or other tariff policies or authorities and other announcements. Issues related to USMCA Supply chain issues and critical materials/minerals. Supply chain/labor issues and implementation.

Issues related to infrastructure, vehicles and vehicle technologies, highways, roads, traffic safety and traffic markings, composites in infrastructure and aerospace applications and standards for composites and freight issues, highway materials, pipelines, including CO2 pipelines, pipeline odorization, hazmat transportation, and shipping issues.

 Bills named in this filing 7
  • H.R. 640
    Chemical Tax Repeal Act
  • S. 615
    Chemical Tax Repeal Act
  • H.R. 1
    One Big Beautiful Bill Act
  • H.R. 9495
    Department of Defense Appropriations Act, 2027
  • S. 4784
    National Defense Authorization Act for Fiscal Year 2027
  • H.R. 5544
    Ejiao Act of 2025
  • S. 2754
    Crystal Reservoir Conveyance Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem